Extremely high rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by innovative sequential use of Nilotinib and Imatinib. A GIMEMA Protocol LAL 1408 / Giovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, Antonella Vitale, Ilaria Iacobucci, Simona Soverini, Francesco D. Raimondo, Stefania Paolini, Massimiliano Bonifacio, Angelo Michele Carella, Mario Cazzola, Antonio Cuneo, Pietro Leoni, Mario Luppi, Enrica Morra, Giorgina Specchia, Loredana Elia, Robin Foà, Michele Baccarani. - In: CANCER RESEARCH. - ISSN 0008-5472. - ELETTRONICO. - 74:19(2014), pp. 5552-5552. [10.1158/1538-7445.AM2014-5552]
Extremely high rate of complete hematological response of elderly Ph+ acute lymphoblastic leukemia (ALL) patients by innovative sequential use of Nilotinib and Imatinib. A GIMEMA Protocol LAL 1408
Giovanni Martinelli;Cristina Papayannidis;Ilaria Iacobucci;Simona Soverini;Stefania Paolini;Antonio Cuneo;Pietro Leoni;Michele Baccarani
2014
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.